Cancer patients at patient advocacy events voice strong support for company's focus on patient quality of life and the highly neglected need for new therapies for cancer therapy-related diarrhea SAN ...

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer. Twenty-eight patients with advanced colorectal cancer refractory to ...

Salix announced that the FDA has approved Fulyzaq (crofelemer) delayed-release tablets for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy ...

Please provide your email address to receive an email when new articles are posted on . “Bile acid diarrhea is a common yet underrecognized cause of chronic watery diarrhea. In most countries, ...

Retrospective observational study: Bevacizumab (B) use and outcomes among metastatic colorectal cancer (mCRC) patients (pts) receiving care in the outpatient community in the United States. Background ...

High levels of a hormone found in cells in the gut could underlie many cases of chronic diarrhea and help explain up to 40% of cases of patients with irritable bowel syndrome with diarrhea, according ...

Almost 3 million outpatient visits to gastroenterology clinics are prompted by diarrhea as the chief complaint, yet evaluating its severity remains inherently subjective. Urinary ammonium plays an ...